(NP (NP (NP Signaling/NN) (PP via/IN (NP-COOD (NP IL-2/NN) and/CC (NP IL-4/NN))) (PP in/IN (NP JAK3-deficient/JJ severe/JJ combined/JJ immunodeficiency/NN lymphocytes/NNS)) :/:) (NP (ADJP-COOD (ADJP JAK3-dependent/JJ) and/CC (ADJP (NP *?*/-NONE-) independent/JJ)) pathways/NNS) ./.)
(S (NP-SBJ-COOD Both/CC (NP IL-2/NN) and/CC (NP IL-4/NN)) (VP bind/VBP (PP to/TO (NP (NP receptors/NNS) (VP containing/VBG (NP-COOD (NP the/DT common/JJ gamma/NN chain/NN) and/CC (NP JAK3/NN)))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ-100 JAK3/NN) (VP is/VBZ (VP required/VBN (NP *-100/-NONE-) (PP for/IN (NP proper/JJ lymphoid/JJ development/NN)))))) ,/, (NP-SBJ-39 (NP the/DT precise/JJ roles/NNS) (PP of/IN (NP this/DT kinase/NN)) (PP in/IN (NP (NP (NP-COOD (NP IL-2/NN) and/CC (NP IL-4/NN)) signaling/NN) (PP in/IN (NP lymphocytes/NNS))))) (VP have/VBP not/RB (VP been/VBN (VP defined/VBN (NP *-39/-NONE-)))) ./.)
(S (ADVP Here/RB) ,/, (NP-SBJ we/PRP) (VP have/VBP (VP studied/VBN (NP (NP (NP-COOD (NP IL-2/NN) and/CC (NP IL-4/NN)) signaling/NN) (PP in/IN (NP (NP B/NN cell/NN lines/NNS) (VP lacking/VBG (NP JAK3/NN))))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ (NP IL-2-induced/JJ phosphorylation/NN) (PP of/IN (NP-COOD (NP IL-2R/NN beta/NN) ,/, (NP JAK1/NN) ,/, and/CC (NP STAT5/NN))) (ADVP all/DT)) (VP required/VBN (NP (NP the/DT presence/NN) (PP of/IN (NP JAK3/NN)))))) ,/, (NP-SBJ (NP IL-4-mediated/JJ phosphorylation/NN) (PP of/IN (NP-COOD (NP JAK1/NN) ,/, (NP STAT6/NN) ,/, and/CC (NP insulin/NN receptor/NN substrates/NNS (NP-COOD (NP 1/CD) and/CC (NP 2/CD)))))) (VP did/VBD not/RB (VP *?*/-NONE-)) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ-40 IL-4-induced/JJ effects/NNS) (VP were/VBD (VP (ADVP clearly/RB) improved/VBN (NP *-40/-NONE-) (PP-TMP following/VBG (NP JAK3/NN expression/NN)))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ IL-4/NN signaling/NN) (VP-COOD (VP occurs/VBZ (PP in/IN the/DT absence/NN of/IN of/IN (NP JAK3/NN))) ,/, but/CC (VP is/VBZ (ADJP-PRD comparatively/RB inefficient/JJ)))))) ./.)
(S (NP-SBJ These/DT findings/NNS) (VP-COOD (VP may/MD (VP help/VB (PP in/RP (S (NP-SBJ */-NONE-) (VP understanding/VBG (NP (NP the/DT pathogenesis/NN) (PP of/IN (NP (NP the/DT immunodeficiency/NN) (SBAR (WHNP-41 that/WDT) (S (NP-SBJ *T*-41/-NONE-) (VP occurs/VBZ (PP with/IN (NP (NP mutations/NNS) (PP of/IN (NP JAK3/NN))))))))))))))) and/CC (VP may/MD (VP suggest/VB (NP (NP a/DT mechanism/NN) (PP for/IN (NP (NP the/DT pleiotropic/JJ effects/NNS) (PP of/IN (NP IL-4/NN)))))))) ./.)
